Profile_bird

Hey there! pharminews is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving pharminews's tweets.

Already using Twitter
from your phone? Click here.

pharminews

  1. Job Detail | Industrial Placement - Country Clinical Trials ... http://bit.ly/6l7oan #pharminews about 9 hours ago from twitterfeed
  2. Job Detail | Field Development Specialist (Tarceva) | PharmiWeb.com http://bit.ly/7oW2gU #pharminews about 9 hours ago from twitterfeed
  3. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder http://bit.ly/4JjvT7 #pharminews about 10 hours ago from twitterfeed
  4. Eisai Launches New Oral Jelly Formulation of Aricept® News Press ... http://bit.ly/8JrAz3 #pharminews about 13 hours ago from twitterfeed
  5. GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed http://bit.ly/8pNmZd #pharminews about 19 hours ago from twitterfeed
  6. Achieving Universal Access: The Way Forward http://bit.ly/8doMYu #pharminews about 19 hours ago from twitterfeed
  7. Men, Partners and Patients in Europe United Against Prostate Cancer http://bit.ly/7rPJC3 #pharminews about 19 hours ago from twitterfeed
  8. Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan http://bit.ly/7elgDA #pharminews about 19 hours ago from twitterfeed
  9. Amgen Highlights Data to be Presented at ASH http://bit.ly/7oq4pb #pharminews about 19 hours ago from twitterfeed
  10. Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan http://bit.ly/4DMHEv #news #pharma about 20 hours ago from twitterfeed
  11. GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed http://bit.ly/6UBNRi #news #pharma about 20 hours ago from twitterfeed
  12. Amgen Highlights Data to be Presented at ASH http://bit.ly/7v04DO #news #pharma about 20 hours ago from twitterfeed
  13. "As an Industry, We've Been too Focused on Regulatory Approval," Says Solvay ... - PharmiWeb.com (p.. http://bit.ly/5W6hZx #pharminews about 20 hours ago from twitterfeed
  14. Men, Partners and Patients in Europe United Against Prostate Cancer http://bit.ly/6wFFU5 #news #pharma about 20 hours ago from twitterfeed
  15. Achieving Universal Access: The Way Forward http://bit.ly/4zWegc #news #pharma about 20 hours ago from twitterfeed
  16. Merck Serono Receives Refuse to File Letter From FDA on Cladribine ... http://bit.ly/7lSsLK #pharminews 7:46 AM Nov 30th from twitterfeed
  17. Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Bi... http://bit.ly/5Ch2KY #news #pharma 4:01 AM Nov 30th from twitterfeed
  18. Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering http://bit.ly/8inDfo #news #pharma 4:01 AM Nov 30th from twitterfeed
  19. GSK becomes London 2012’s 25th sponsor http://bit.ly/5Crpqd #pharminews 3:54 AM Nov 30th from twitterfeed
  20. arghh!! - Pharma CVs - The Top Ten Mistakes - http://bit.ly/pharmacvmistakes 10:48 AM Nov 26th from TweetDeck